FDA bars Michigan firm from selling heart machines

Mar 22, 2011

(AP) -- The federal government is legally barring a Michigan company from selling life-sustaining devices used in heart surgery, following years of quality control problems at company facilities.

The said Tuesday it signed a permanent injunction with Terumo Cardiovascular Systems and two executives that bars them from making and distributing heart-lung bypass systems and similar machines to new customers. The devices are used to circulate blood during chest surgery.

Terumo agreed to pay $35 million in back profits from the sale of its devices and additional fines if it doesn't comply with the government's terms.

The legal document finalizing the agreement will be filed in the U.S. District Court for the Eastern District of Michigan by the U.S. Department of Justice.

Last March, FDA inspectors reported more than a dozen quality control violations at the company's plant in Ann Arbor. The problems involved company procedures for dealing with defective products, customer complaints and product design. The FDA cited Terumo for similar problems in 2004 and 2006.

The FDA said it is not recalling Terumo's products from the market because of concerns about a shortage of the machines. Additionally, the company will be allowed to service and replace existing machines.

The company said in a statement it is already working to fix the issues.

"Over the past year, Terumo has already begun implementing a significant quality system initiative that will create systemic, sustainable improvements in its quality systems," said Mark Sutter, president and chief executive of Terumo Cardiovascular Systems.

Terumo Cardiovascular is subsidiary of Terumo Corp., which is headquartered in Tokyo.

Explore further: New treatment approved for rare form of hemophilia

5 /5 (2 votes)
add to favorites email to friend print save as pdf

Related Stories

Heart defibrillator company signs decree

May 01, 2008

The U.S. Food and Drug Administration said Medtronic Inc. has agreed to comply with FDA rules in manufacturing its external heart defibrillators.

FDA found bacteria in lots for recalled Tylenol

May 04, 2010

(AP) -- Ingredients used by Johnson & Johnson in some of the 40 varieties of children's cold medicines recalled last Friday were contaminated with bacteria, according to a report by the Food and Drug Administration.

Puerto Rican dairy injunction issued

Aug 14, 2007

An injunction has been issued against two Puerto Rican dairies because of alleged drug residue found in cows, the U.S. Food and Drug Administration said.

FDA warning for hand sanitizer in Puerto Rico

Mar 05, 2010

(AP) -- Puerto Rico's government sent inspectors across the island Thursday to stop stores from selling locally produced hand sanitizers tainted with a dangerous bacteria.

FDA to study negative effects of Lasik eye surgery

Oct 16, 2009

(AP) -- The Food and Drug Administration announced plans Thursday to study the scope of problems connected with laser eye-correcting surgery, which include blurred vision and dry eyes.

Recommended for you

WHO: Millions of Ebola vaccine doses ready in 2015

17 hours ago

The World Health Organization says millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines will start being tested in March.

Added benefit of vedolizumab is not proven

Oct 23, 2014

Vedolizumab (trade name Entyvio) has been approved since May 2014 for patients with moderately to severely active Crohn disease or ulcerative colitis. In an early benefit assessment pursuant to the Act on the Reform of the ...

Seaweed menace may yield new medicines

Oct 22, 2014

An invasive seaweed clogging up British coasts could be a blessing in disguise. University of Greenwich scientists have won a cash award to turn it into valuable compounds which can lead to new, life-saving drugs.

User comments : 0